Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Total Current Liabilities (2016 - 2025)

Iradimed (IRMD) has disclosed Total Current Liabilities for 13 consecutive years, with $10.2 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 19.6% to $10.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.2 million through Dec 2025, up 19.6% year-over-year, with the annual reading at $10.2 million for FY2025, 19.6% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $10.2 million at Iradimed, down from $12.8 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $16.3 million in Q4 2023, with the low at $4.6 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $8.1 million, with a median of $7.6 million recorded in 2023.
  • The sharpest move saw Total Current Liabilities surged 90.88% in 2023, then plummeted 47.87% in 2024.
  • Over 5 years, Total Current Liabilities stood at $6.8 million in 2021, then rose by 25.37% to $8.6 million in 2022, then surged by 90.88% to $16.3 million in 2023, then crashed by 47.87% to $8.5 million in 2024, then rose by 19.6% to $10.2 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $10.2 million, $12.8 million, and $8.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.